Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T23:19:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T23:06:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2; the study record content is still unavailable.
    Difference
    0.2%
    Check dated 2026-10-19T23:23:28.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site revision displayed in the error-page footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T05:36:41.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The record's revision tag was updated to v3.7.0, indicating a new version of the page template; the prior revision metadata (v3.6.6) has been superseded.
    Difference
    17%
    Check dated 2026-09-21T23:27:35.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting a minor update to the page's metadata. No study content or visible functionality is altered.
    Difference
    0.1%
    Check dated 2026-08-31T18:55:27.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.